Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: Nov 12, 2024
BERKELEY HEIGHTS, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines, today announced third quarter financial results and provided a business update.
Read more at globenewswire.comNASDAQ:CYCC (7/24/2025, 9:48:09 AM)
17.3
+3.3 (+23.57%)
CYCLACEL PHARMACEUTICALS - CYCC 6 PERP
NASDAQ:CYCCP (7/23/2025, 8:14:48 PM)
Premarket: 5.09 +0.44 (+9.46%)4.65
-0.34 (-6.81%)
Find more stocks in the Stock Screener
CYCC Latest News and Analysis
